Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000898432-03-000721
Filing Date
2003-08-08
Accepted
2003-08-07 19:59:41
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 sc13da.txt SC 13D/A 30220
  Complete submission text file 0000898432-03-000721.txt   32421
Mailing Address 3030 SCIENCE PARK ROAD SAN DIEGO CA 92121
Business Address 3030 SCIENCE PARK RD SAN DIEGO CA 92121 6194559800
CORVAS INTERNATIONAL INC (Subject) CIK: 0000882100 (see all company filings)

EIN.: 330238812 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-42011 | Film No.: 03829865
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

EIN.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice